CN102335243B - Chinese medicinal composition for treating icteric hepatitis - Google Patents

Chinese medicinal composition for treating icteric hepatitis Download PDF

Info

Publication number
CN102335243B
CN102335243B CN 201110313320 CN201110313320A CN102335243B CN 102335243 B CN102335243 B CN 102335243B CN 201110313320 CN201110313320 CN 201110313320 CN 201110313320 A CN201110313320 A CN 201110313320A CN 102335243 B CN102335243 B CN 102335243B
Authority
CN
China
Prior art keywords
parts
radix
treatment
herba
chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201110313320
Other languages
Chinese (zh)
Other versions
CN102335243A (en
Inventor
潘月玲
战祥峰
潘月娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201110313320 priority Critical patent/CN102335243B/en
Publication of CN102335243A publication Critical patent/CN102335243A/en
Application granted granted Critical
Publication of CN102335243B publication Critical patent/CN102335243B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicinal composition for treating icteric hepatitis. The composition consists of virgate wormwood herb, Chinese rhubarb, ageratum, fortune eupatorium herb, Chinese angelica, the rhizome of Chinese atractylode, bighead atractylodes rhizome, prepared common monkshood daughter root and liquorice, has the efficacies of clearing away heat and expelling toxic materials, drying dampness and strengthening spleen, and has a short course of treatment, a remarkable curative effect and no toxic or side effect. According to the statistics on observation to 125 clinical patients, the total effective rate of the patients taking the medicament for one course of treatment is 86.4 percent, while the total effective rate of the patients taking the medicament for two courses of treatment is 94.4 percent.

Description

A kind of Chinese medicine composition for the treatment of icterohepatitis
Technical field
The present invention relates to a kind of Chinese medicine composition, especially a kind of Chinese medicine composition for the treatment of icterohepatitis.
Background technology
The traditional Chinese medical science thinks, jaundice is to be obstructed by the liver and gall mechanism of qi, and catharsis is not normal.Bile is excessive, the disease of liver-gallbladder take icteric sclera, yellowish body, yellowish urine as main manifestations.Its cause of disease has the seasonal pathogen of impression epidemic disease poison, or is injury due to diet, or is weakness of the spleen and stomach, and it is suffered from inside and outside often occuring mutually each other.Mainly be damp from pathogenic factor, such as " Medical Treasures of the Golden Chamber, Shanghai: jaundice abnormal pulse card is also controlled " " yellow family gained, caused by pathogenic dampness " arranged.And among the internal organs, the transporting that taste master water is wet is therefore the prosperity and decline of the morbidity of jaundice and spleen and stomach function has close relationship.At present, the Western medicine for the treatment of icterohepatitis class is mainly and suppresses viral the liver protecting and ALT lowering, and from current, these medicines are scarcely desirable, middle medical drugs is uneven again, mix the genuine with the fictitious, be difficult to gather effect, delay the state of an illness, in the course of time become chronic hepatitis, the criminal controls for a long time for a long time, obstinate, even be converted into liver cirrhosis so that canceration.
Summary of the invention
Main task of the present invention provides a kind of Chinese medicine composition for the treatment of icterohepatitis, and this medicine has heat-clearing and toxic substances removing, drying damp and strengthening spleen effect.
The present invention selects Herba Artemisiae Scopariae, Radix Et Rhizoma Rhei, Herba Pogostemonis, Herba Eupatorii, Radix Angelicae Sinensis, the Rhizoma Atractylodis Rhizoma Atractylodis Macrocephalae, Radix Aconiti Lateralis Preparata, Radix Glycyrrhizae to make up, with these drug regimens so that each efficacy of drugs produces synergism, make it to have heat-clearing and toxic substances removing, drying damp and strengthening spleen effect, thereby can effectively treat icterohepatitis.
Wherein, Herba Artemisiae Scopariae: be the seedling of feverfew Herba Artemisiae Scopariae Artemisia capillaris Thunb..Cold nature, acrid in the mouth, hardship.Return spleen, stomach, liver, gallbladder meridian.Has clearing away damp-heat, the effect of jaundice eliminating subcutaneous ulcer.Be used for jaundice oliguria, infectious jaundice type hepatitis.Herba Artemisiae Scopariae has significant hepatoprotective effect, to first, and hepatitis B, icterohepatitis has significant curative effect.Function of gallbladder promoting is arranged, promote bile secretion, the effect that cholic acid and bilirubin are discharged in the increase bile.
Radix Et Rhizoma Rhei: be root and the rhizome of polygonum rheum palmatum, Rheum tanguticum or Rheum officinale.Nature and flavor, hardship, cold.Return stomach, Liver Channel, spleen channel.Has clearing away damp-heat, removing heat from blood, the effect of detoxifcation.
Herba Pogostemonis: be the labiate Herba Pogostemonis Agastache rugosaThe aerial parts of (Fisch. et Mey.) O. Ktze..Acrid in the mouth; Slightly warm in nature.Return lung; Spleen; The stomach warp.Effect with dispelling summer-heat from superficies of the body, removing dampness to restore normal function of the stomach.
Herba Eupatorii: be the aerial parts of feverfew Herba Eupatorii (Herba Chlorophyti) Eupatorium fortunei Turcz..Nature and flavor are hot, and are flat.Return spleen, stomach, lung meridian.Effect with clearing away heat and eliminating dampness, anti inflammatory detoxication.
Radix Angelicae Sinensis: be the dry root of umbelliferae angelica Angelica sinensis (Oliv.) Diels.Warm in nature, sweet in the mouth, suffering.Return liver, the heart, spleen channel.Having enriches blood invigorates blood circulation, the effect of loosening bowel to relieve constipation.Hepatic injury there is protective effect, and can promotes liver cell regeneration and the effect that recovers some function of liver.
Rhizoma Atractylodis: be the Compositae herbaceos perennial, the rhizome of Atractylodes lancea (Thunb.) DC. (RHIZOMA ATRACTYLODIS IANCEAE) or Atractylis chinensis.Nature and flavor are hot, bitter, temperature.Return spleen, stomach, Liver Channel.Have drying damp and strengthening spleen, the effect of expelling wind and cold.
The Rhizoma Atractylodis Macrocephalae: be the dry rhizome of feverfew Rhizoma Atractylodis Macrocephalae Atractylodes macrocephala Koidz..Nature and flavor are bitter, sweet, temperature.Return spleen, stomach warp.Effect with invigorating the spleen and benefiting QI, dampness diuretic.
Radix Aconiti Lateralis Preparata: be the processed goods of the daughter root of ranunculaceae plant Aconitum carmichjaelii Debx. aconitum carmichaeli debx..Nature and flavor are hot, sweet, large heat; Poisonous.GUIXIN, kidney, spleen channel.
Radix Glycyrrhizae: be dicotyledon pulse family Leguminosae Radix Glycyrrhizae Glycyrrhiza uralensisFisch., Glycyrrhiza inflata Bat. G. inflataOr Glycyrrhiza glabra L. Bat., G. glabraL. root and rhizome.Property is put down, and sweet in the mouth is returned 12 warps.Has invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, the effect of coordinating the actions of various ingredients in a prescription.Be used for weakness of the spleen and stomach, fatigue and weakness has antiinflammatory, antiviral, and the effects such as protecting liver and detoxication and enhancing immunologic function.Because glycyrrhizic acid has the pharmacological action of glucocorticoid sample and without serious adverse reaction, clinically be widely used in treating the functions such as various acute, chronic hepatitis, interferon inducer and cell immunomodulator.
Medicine material consumption of the present invention is groped to sum up to draw through the inventor in a large number, and each material medicine consumption all has preferably therapeutic effect in the scope of following weight parts: 10-20 parts of Herba Artemisiae Scopariaes, 5-15 parts of Radix Et Rhizoma Rhei, 10-20 parts of Herba Pogostemoniss, 10-20 parts of Herba Eupatoriis, 10-20 parts of Radix Angelicae Sinensis, 10-20 parts of Rhizoma Atractylodis, 10-20 parts of the Rhizoma Atractylodis Macrocephalaes, 3-8 parts of Radix Aconiti Lateralis Preparatas, 1-5 parts in Radix Glycyrrhizae.
It is preferably: 15 parts of Herba Artemisiae Scopariaes, 9 parts of Radix Et Rhizoma Rhei, 15 parts of Herba Pogostemoniss, 15 parts of Herba Eupatoriis, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Atractylodis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Aconiti Lateralis Preparatas, 3 parts in Radix Glycyrrhizae.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, such as pill, powder, tablet, capsule, oral liquid etc.For example, these medicine material grind into powder mix homogeneously can be made powder takes after mixing it with water; Can use decocting, get after filtration filtrate, add antiseptic and make oral liquid; Also can directly take decoction in case of necessity.
The specific embodiment
Embodiment one, 10 parts of Herba Artemisiae Scopariaes, 5 parts of Radix Et Rhizoma Rhei, 10 parts of Herba Pogostemoniss, 10 parts of Herba Eupatoriis, 10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Atractylodis, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 3 parts of Radix Aconiti Lateralis Preparatas, 1 part in Radix Glycyrrhizae.
Embodiment two, 15 parts of Herba Artemisiae Scopariaes, 9 parts of Radix Et Rhizoma Rhei, 15 parts of Herba Pogostemoniss, 15 parts of Herba Eupatoriis, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Atractylodis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Aconiti Lateralis Preparatas, 3 parts in Radix Glycyrrhizae.
Embodiment three, 20 parts of Herba Artemisiae Scopariaes, 15 parts of Radix Et Rhizoma Rhei, 20 parts of Herba Pogostemoniss, 20 parts of Herba Eupatoriis, 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Atractylodis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts of Radix Aconiti Lateralis Preparatas, 5 parts in Radix Glycyrrhizae.
The below is the clinical statistics data that the patient uses medicine of the present invention:
One, physical data
Accept 125 examples for medical treatment and be in hospital and the out-patient, wherein, male's 78 examples, women's 47 examples, 36 years old mean age, all cases all meets the icterohepatitis diagnostic criteria of nineteen ninety-five infectious disease parasitic disease association formulation.
Two, diagnostic criteria
Fear of cold, heating, weak, loss of appetite, nausea and vomiting, detest oil, pale tongue with thin fur is white and slide thready and moderate pulse.There are in various degree skin yellow sclera, urine buff, most of case to have liver pain and percussion pain, hepatomegaly, liver function test to show that the some patients were routine blood test is unusual significantly unusually within one week.
Three, Therapeutic Method
Take embodiment two as example, according to the drug weight part weighting raw materials (daily dose) among the embodiment two, carry out decocting with the decocting method of Chinese medicine decoction routine, filter and remove residue is taken at twice, sooner or later each once, seven is a course for the treatment of.
Four, efficacy assessment standard
Produce effects: patient's fear of cold, weak, poor appetite, feel sick, clinical fundamental symptoms and the sign complete obiteration such as yellowish urine, observing jaundice disappears, bilirubin, transaminase level all recover normally substantially;
Effectively: patient's fear of cold, weak, poor appetite, feel sick, the clinical fundamental symptoms such as yellowish urine alleviates to some extent with sign, observes jaundice to shoal to some extent, bilirubin, transaminase level all have obvious decline before the treatment but recover normally;
Invalid: patient's clinical fundamental symptoms and sign, the performance of observation jaundice, bilirubin level, transaminase level are treated front nothing significantly improvement or to some extent deterioration.
Five, treatment statistical result
Figure 2011103133209100002DEST_PATH_IMAGE001
Total effective rate=(produce effects+effectively)/total routine number * 100%.
Model case:
1, Chen, woman, people from Juxian County, 42 years old, because the unable 1 week companion xanthochromia of anorexia occurred together hot 3 days, medical on June 8th, 2010, the patient is medical doctor trained in Western medicine internal clinic first, and through the liver function chemical examination, the result shows icterohepatitis, change the treatment of my section over to, the patient except above-mentioned symptom, the time have right flank section dull pain uncomfortable, nauseating nausea, yellow urine, stool is normal, the red tongue tongue is greasy in vain, slippery and rapid pulse.Tcm diagnosis is jaundice (damp and hot laying equal stress on), uses prescription of the present invention, minute morning, late twice decoction being taken warmly behind 2 mixings of decocting, 1 day 1 dose, after taking medicine 3 days, sclera, xanthochromia is clearly better, symptom also has and alleviates, after taking 3 doses, xanthochromia and transference cure, the blood test liver function is normal, the patient disease recovery from illness is gone back with satisfaction.
2, Zhang, man, people from Juxian County, 35 years old, because of xanthochromia, enter the treatment of my section, fear of cold, heating, weak, loss of appetite, nausea and vomiting are arranged, detest the wet goods symptom, pale tongue with thin fur is slided in vain, and thready and moderate pulse, tcm diagnosis are jaundice (damp and hot laying equal stress on), use prescription of the present invention, behind 2 mixings of decocting minute early, late twice decoction being taken warmly, 1 day 1 dose, xanthochromia is clearly better after taking medicine 7, and symptom also alleviates to some extent, after taking 3 doses, xanthochromia and transference cure, the blood test liver function is normal, the patient disease recovery from illness.

Claims (2)

1. a Chinese medicine composition for the treatment of icterohepatitis is characterized in that being comprised of the crude drug of following weight portion: 10-20 parts of Herba Artemisiae Scopariaes, 5-15 parts of Radix Et Rhizoma Rhei, 10-20 parts of Herba Pogostemoniss, 10-20 parts of Herba Eupatoriis, 10-20 parts of Radix Angelicae Sinensis, 10-20 parts of Rhizoma Atractylodis, 10-20 parts of the Rhizoma Atractylodis Macrocephalaes, 3-8 parts of Radix Aconiti Lateralis Preparatas, 1-5 parts in Radix Glycyrrhizae.
2. the Chinese medicine composition for the treatment of icterohepatitis according to claim 1, the weight portion that it is characterized in that each crude drug is 15 parts of Herba Artemisiae Scopariaes, 9 parts of Radix Et Rhizoma Rhei, 15 parts of Herba Pogostemoniss, 15 parts of Herba Eupatoriis, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Atractylodis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Aconiti Lateralis Preparatas, 3 parts in Radix Glycyrrhizae.
CN 201110313320 2011-10-17 2011-10-17 Chinese medicinal composition for treating icteric hepatitis Expired - Fee Related CN102335243B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110313320 CN102335243B (en) 2011-10-17 2011-10-17 Chinese medicinal composition for treating icteric hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110313320 CN102335243B (en) 2011-10-17 2011-10-17 Chinese medicinal composition for treating icteric hepatitis

Publications (2)

Publication Number Publication Date
CN102335243A CN102335243A (en) 2012-02-01
CN102335243B true CN102335243B (en) 2013-01-16

Family

ID=45511344

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110313320 Expired - Fee Related CN102335243B (en) 2011-10-17 2011-10-17 Chinese medicinal composition for treating icteric hepatitis

Country Status (1)

Country Link
CN (1) CN102335243B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103550740B (en) * 2013-11-01 2015-06-10 杨献华 Traditional Chinese medicinal composition for treating icterohepatitis and application of traditional Chinese medicinal composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101757541A (en) * 2009-11-05 2010-06-30 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating liver ascites symptoms and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101757541A (en) * 2009-11-05 2010-06-30 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating liver ascites symptoms and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
叶望云.小儿黄疸的辨证施治.《中国临床医生》.2000,第28卷(第05期),
小儿黄疸的辨证施治;叶望云;《中国临床医生》;20000531;第28卷(第05期);第13页第1栏第1-3段,第14页第1栏倒数第1段-第2栏倒数第2段 *
李晓倩等.茵陈蒿汤临床应用研究进展.《中医药临床杂志》.2009,第21卷(第01期),
茵陈蒿汤临床应用研究进展;李晓倩等;《中医药临床杂志》;20090228;第21卷(第01期);82-85 *

Also Published As

Publication number Publication date
CN102335243A (en) 2012-02-01

Similar Documents

Publication Publication Date Title
CN101468171B (en) Medicament for weight-reducing of fat people and weight-gaining of thin people
CN103007191B (en) Chinese medicinal composition for treating jaundice
CN103071128B (en) Externally-applied plaster for curing dysmenorrhea
CN103169805A (en) Medicament for treating meniscus injury
CN104491755A (en) Traditional Chinese medicine composition for treating abdominal distension and preparation method of traditional Chinese medicine composition
CN102526566B (en) Chinese medicine preparation for treating hysteromyoma and ovaricyst and preparation method
CN102600426B (en) Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof
CN101862424A (en) Chinese medicinal composition for treating hepatitis B and preparation method thereof
CN100409870C (en) Chinese traditional medicinal composition for treating psoriasis
CN104225166A (en) Chinese medicine composition for treating amenorrhea and preparation method thereof
CN103990078A (en) Traditional Chinese medicine composition for treating jaundice hepatitis
CN103356932B (en) A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia
CN101926903A (en) Chinese medicine preparation for curing facial paralysis
CN102335243B (en) Chinese medicinal composition for treating icteric hepatitis
CN103690869B (en) Chinese medicine for the treatment of irritable bowel syndrome and preparation method thereof
CN102188510B (en) Traditional Chinese medicine composition for treating sand-like cholelithiasis
CN101269191B (en) Externally applied medicament for treating hepatopathy
CN104027430A (en) Traditional Chinese medicine composition for treating blood stasis type uterine myoma
CN103191379B (en) Traditional Chinese medicinal composition for treating cirrhosis
CN102166303B (en) Chinese medicinal composition for treating chronic atrophic gastritis
CN101985027A (en) Chinese herbal medicine for treating liver cirrhosis
CN103656199B (en) A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough
CN102488851A (en) Drug for treating recurrent genital herpes and preparation method thereof
CN102309725B (en) Traditional Chinese medicine preparation for treating hepatitis B cirrhosis and preparation method
CN105232609A (en) Traditional Chinese medicine combination treating functional dyspepsia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130116

Termination date: 20131017